Journal article
CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation
Journal of psychopharmacology (Oxford), Vol.28(12), pp.1143-1148
12/2014
DOI: 10.1177/0269881114543720
PMID: 25122046
Abstract
Recently, a FDA Safety Communication warned of a dose-dependent risk for QTc prolongation with citalopram, which is metabolized by CYP2C19 of the cytochrome P450 system. We investigate associations between citalopram and escitalopram dose, serum concentration, CYP2C19 phenotype, and QTc. We undertook a retrospective chart review of citalopram or escitalopram patients with the inclusion criteria of consistent medication dose, CYP2C19 phenotype (extensive metabolizers [EM], intermediate metabolizers [IM], poor metabolizers [PM]), and QTc interval on ECG. We further identified 42 citalopram users with citalopram serum concentration measurements and ECG. Regression and one-way ANOVA were used to examine the relationship between citalopram dose, citalopram serum concentration, CYP2C19 phenotype, and QTc interval. Of 75 citalopram patients, the EM group had significantly shorter QTc intervals than a combined IM+PM group (427.1±23.6 ms vs. 440.1±26.6 ms, one-tailed t-test, p=0.029). In the 80 escitalopram cohort, there was no significant difference in QTc between phenotype groups. There was no statistical correlation between citalopram (p=0.62) or escitalopram (p=0.30) dose and QTc. QTc was not associated with citalopram serum level (p=0.45). In contrast to the FDA warning, this study found no association between citalopram/escitalopram dose and QTc. However, PM of the drug tended to have longer QTc intervals. Our findings suggest cytochrome P450 genotyping in select patients may be helpful to guide medication optimization while limiting harmful effects.
Details
- Title: Subtitle
- CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation
- Creators
- Yingying Kumar - Mayo Medical School, Mayo Clinic, Rochester, MN, USASimon Kung - Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USAGen Shinozaki - Department of Psychiatry, University of Iowa, Iowa City, IA, USA gen-shinozaki@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Journal of psychopharmacology (Oxford), Vol.28(12), pp.1143-1148
- Publisher
- United States
- DOI
- 10.1177/0269881114543720
- PMID
- 25122046
- ISSN
- 0269-8811
- eISSN
- 1461-7285
- Language
- English
- Date published
- 12/2014
- Academic Unit
- Psychiatry; Anesthesia; Neurosurgery
- Record Identifier
- 9984003427602771
Metrics
17 Record Views